Health related quality of life and related factors among children with transfusion dependent thalassemia: a cross-sectional study in Chattogram, Bangladesh

Mitra Datta; Sharmistha Dhar; Tumpa Dhar; Kamrun Nahar; Zabeen Choudhury; S. M. Rezanur Rahman; Sanjana Islam; Ashfak Al Arif Shuvon

doi:10.18203/2320-6012.ijrms20261321

Authors

Mitra Datta Department of Pediatrics, Chittagong Medical College, Chattogram, India
Sharmistha Dhar Department of Obstetrics and Gynecology, Chattogram Maa-O-Shishu Hospital Medical College, Chattogram, Bangladesh
Tumpa Dhar Department of Pediatrics, Chittagong Medical College, Chattogram, India
Kamrun Nahar Department of Pediatrics, Chittagong Medical College, Chattogram, India
Zabeen Choudhury Department of Pediatrics, Chittagong Medical College, Chattogram, India
S. M. Rezanur Rahman Department of Pediatric Hematology & Oncology, Chittagong Medical College, Chattogram, Bangladesh
Sanjana Islam Department of Pediatrics, Chattogram Ma-O-Shishu Hospital, Chattogram, Bangladesh
Ashfak Al Arif Shuvon Bangladesh University of Health Sciences, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261321

Keywords:

Transfusion-dependent thalassemia, Health-related quality of life, TranQol, Pediatric thalassemia, Bangladesh, Hierarchical multiple regression, Iron overload

Abstract

Background: Transfusion-dependent thalassemia (TDT) is a chronic inherited disorder requiring lifelong transfusions and iron chelation. Despite improved survival, complications and treatment burden reduce health-related quality of life (HRQoL). Evidence from Bangladesh using disease-specific tools is limited. This study assessed HRQoL and its associated factors among children with TDT in Chattogram.

Methods: A cross-sectional study was conducted among 400 children (6–18 years) at two tertiary hospitals in Chattogram. HRQoL was measured using the Bangla-translated TranQol questionnaire (physical, emotional, family and school/career domains). Sociodemographic and clinical data were collected via interviews and records. Data were analyzed using non-parametric tests, correlation and hierarchical multiple linear regression in SPSS v27, with p<0.05 considered significant.

Results: Most participants were aged 10–15 years (58.0%) and male (68.5%), with HbE thalassemia as the predominant type (70.0%). Mean serum ferritin was high (2082.6±1353.7 ng/ml) and 54.5% received iron chelation therapy. Physical health had the lowest HRQoL score (6.07/24), followed by family (11.32/36), emotional (14.13/36) and school/career (9.45/16). Sociodemographic and family factors explained 31.8%, 26.1%, 16.6% and 24.6% of variance across domains, respectively (all p<0.001). Age at diagnosis and residence were consistent significant predictors.

Conclusions: Children with TDT in Bangladesh experience substantial multidimensional impairment in HRQoL. Early age at diagnosis, iron overload and socioeconomic constraints significantly influence outcomes. Integrating routine HRQoL assessment and strengthening psychosocial and financial support mechanisms are essential to improve holistic thalassemia care.

References

Tuo Y. Global, regional and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021. E Clin Med. 2024;72:102619.

Mitro A, Hossain D, Rahman MM, Dam B, Hosen MJ. β-Thalassemia in Bangladesh: Current status and future perspectives. Thalassemia Reports. 2024;14(3):49-59.

Cappellini MD. Quality of life in patients with beta-thalassemia: a prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon and Thailand. Am J Hematol. 2019;94(10):261-4.

Forni GL, Grazzini G, Boudreaux J, Agostini V, Omert L. Global burden and unmet needs in the treatment of transfusion-dependent β-thalassemia. Front Hematol. 2023;2:1187681.

Azarkeivan A, Hajibeigi B, Alavian SM, Lankarani MM, Assari S. Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia. J Res Med Sci. 2009;14(6):349-55.

Klaassen RJ. Introducing the TranQol: a new disease-specific quality of life measure for children and adults with thalassemia major. J Blood Disord Transfus. 2013;4(4):784

Klaassen RJ. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014;164(3):431-7.

Mettananda S. Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study. Health Qual Life Outcomes. 2019;17:1-13.

Shafie AA. Health-related quality of life among children with transfusion-dependent thalassemia: a cross-sectional study in Malaysia. Health Qual Life Outcomes. 2020;18:1-11.

Alshamsi S, Hamidi S, Narci HO. Health-related quality of life and associated factors of children with transfusion-dependent thalassemia in Dubai, United Arab Emirates. Global J Health Sci. 2021;13(7):18-31.

Karimi M. Quality of life in beta-thalassemia major. Arch Iranian Med. 2007;10(3):372-7.

Thavorncharoensap M. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Ped. 2010;10:1.

Hakeem GLA, Mousa SO, Moustafa AN, Mahgoob MH, Hassan EE. Health-related quality of life in pediatric and adolescent patients with transfusion-dependent β-thalassemia in upper Egypt (single center study). Health Qual Life Outcomes. 2018;16(1):59.

Musallam KM. Iron overload and morbidity in transfusion-dependent thalassemia. Blood. 2011;118(4):884-93.

Sobota A. Self-reported quality of life in thalassemia. Am J Hematol. 2011;86(1):92-8.

Koutelekos I. Quality of life in children with thalassemia. Health Sci J. 2013;7(2):148-59.

Ansari SH. Quality of life in patients with thalassemia major. Indian J Pediatr. 2014;81(4):345-50.

Ismail A. Health-related quality of life among thalassemia patients. Asian J Transfus Sci. 2013;7(2):95-100.

Musallam KM, Cappellini MD, Taher AT. Iron overload in beta-thalassemia intermedia. Haematologica. 2012;97(11):1645-52.

Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes. 2006;4:39.

Taher AT, Cappellini MD. Management of non-transfusion-dependent thalassemia: a practical guide. Drugs. 2014;74(15):1719-29.

Ayoub MD, Radi SA, Azab AM. Quality of life among children with beta-thalassemia major treated in Western Saudi Arabia. Saudi Med J. 2013;34(12):1281-6.

Ababneh S, Siyam AA, Alzoubi MM, Al-Sawalha NA, Al Sukhni FF, Al Rahbeni T, Al-Mugheed K, Farghaly Abdelaliem SM. Assessment of health-related quality of life in transfusion dependent beta thalassemia. Scientific Reports. 2025;15(1):32267.

Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th ed. Oxford: Blackwell Science; 2001.

Khurana A, Katyal M, Marwaha RK. Psychosocial burden in thalassemia. Indian J Pediatr. 2006;73(10):877-80.